Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000501

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Williams Gregory C. · CHIEF EXECUTIVE OFFICER

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-02-25 Grant or award : show line 1 in the form Stock Options +400,000 400,000 D
2020-02-25 Grant or award : show line 2 in the form Restricted Stock Units +200,000 200,000 D
Loading xslF345X03/form4-02262020_040214.xml…